Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Neurology
  4. A randomised, patient-assessor blinded, sham-controlled trial of external non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve injury (EN-PENS trial): study protocol for a randomised controlled trial

A randomised, patient-assessor blinded, sham-controlled trial of external non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve injury (EN-PENS trial): study protocol for a randomised controlled trial

Trials, 2016 · DOI: 10.1186/s13063-016-1709-2 · Published: November 15, 2016

NeurologyPain Management

Simple Explanation

This study aims to assess the effectiveness of external non-invasive peripheral nerve stimulation (EN-PENS) for chronic neuropathic pain after peripheral nerve injury. EN-PENS involves placing a pen-shaped electrode on the skin for self-administration and may relieve localized neuropathic pain. The trial will compare EN-PENS treatment against a control treatment in patients with moderate to severe neuropathic pain.

Study Duration
36 Months
Participants
76 patients with longstanding neuropathic pain following peripheral nerve injury
Evidence Level
Level 1: Randomized controlled parallel-group superiority add-on trial

Key Findings

  • 1
    The primary outcome is average 24-h pain intensity recorded on an 11-point numerical rating scale, averaged over the last 7 days of treatment.
  • 2
    The study will also evaluate the impact of EN-PENS on quality of life and day-to-day function.
  • 3
    The results will inform the potential treatment efficacy and cost-effectiveness of EN-PENS for neuropathic pain.

Research Summary

The EN-PENS trial is a single-site, blinded, randomised controlled parallel-group superiority add-on trial with a 1:1 allocation ratio. Seventy-six patients will be randomised to receive either active or control (sham) treatment. The study duration will be 36 months (from study setup to analysis).

Practical Implications

Treatment Efficacy

The study will provide evidence on the clinical efficacy of EN-PENS in reducing neuropathic pain.

Cost-Effectiveness

The study will evaluate the cost-effectiveness of EN-PENS as a treatment option.

Quality of Life

The study will assess the impact of EN-PENS on patients' quality of life and daily function.

Study Limitations

  • 1
    Single-site study
  • 2
    Limited generalizability due to specific inclusion/exclusion criteria
  • 3
    Potential for patient dropout affecting statistical power

Your Feedback

Was this summary helpful?

Back to Neurology